Obserbation on the effect of the long-term low-dose mifepristone on the treatment of hysteromyoma
10.3969/j.issn.1005-1678.2017.07.125
- VernacularTitle:长期小剂量米非司酮治疗子宫肌瘤的疗效观察
- Author:
Yeli YANG
;
Yongying WANG
- Keywords:
mifepristone;
hysteromyoma;
follicle-stimulating hormone;
estrogen progesterone
- From:
Chinese Journal of Biochemical Pharmaceutics
2017;37(7):306-307
- CountryChina
- Language:Chinese
-
Abstract:
Objective To observe the effect of the long-term low-dose mifepristone on the treatment of hysteromyoma.Methods From March 2016 to December 2016 in Haiyan maternal and child health-care center,120 cases with hysteromyoma were selected as the object study and were given long term oral low-dose mifepristone.The uterus size, follicle stimulating hormone, myoma size, luteinizing hormone, estrogen and endometrium were observed Resultsafter treatment, the patients with uterine fibroids situation improved markedly, and appeared amenorrhea.At the same time, in patients with clinical symptoms were improved to a certain extent, six months after a drug follicle-stimulating hormone, luteinizing hormone and estrogen levels significantly decreased, and there is no other significant side effects.In addition, on the analysis of the effectiveness of the treatment,86 cases were markedly improved,28 cases effective,6 cases ineffective, the total effective rate was 95%.Conclusion Long-term low-dose mifepristone has worked well in the treatment of uterine fibroids, can effectively reduce uterine fibroids, high security, in the process of follow-up of patients, no recurrence no satisfaction related data, the result can't reach this Conclusion , the authors modify please.Is the ideal way of conservative treatment of uterine fibroids, and is worth popularizing in the process of clinical application.
